Drug Shortage Report for WIXELA INHUB
| Report ID | 156586 |
| Drug Identification Number | 02495619 |
| Brand name | WIXELA INHUB |
| Common or Proper name | fluticasone propionate and salmeterol inhalation powder |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | SALMETEROL FLUTICASONE PROPIONATE |
| Strength(s) | 50MCG 500MCG |
| Dosage form(s) | POWDER |
| Route of administration | INHALATION |
| Packaging size | 60 INH |
| ATC code | R03AK |
| ATC description | ADRENERGICS, INHALANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-03-09 |
| Actual start date | |
| Estimated end date | 2022-03-22 |
| Actual end date | 2022-03-15 |
| Shortage status | Resolved |
| Updated date | 2022-03-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2022-03-16 | English | Compare |
| v4 | 2022-03-15 | French | Compare |
| v3 | 2022-03-15 | English | Compare |
| v2 | 2022-03-11 | French | Compare |
| v1 | 2022-03-11 | English | Compare |
Showing 1 to 5 of 5